Craig Hallum reissued their buy rating on shares of Encompass Health (NYSE:EHC) in a research note issued to investors on Tuesday, The Fly reports. They currently have a $60.00 price target on the stock, up from their prior price target of $54.00.
Separately, Bank of America upgraded Encompass Health from an underperform rating to a neutral rating in a research report on Thursday, January 4th.
Shares of Encompass Health (EHC) traded up $0.84 during trading on Tuesday, hitting $50.51. The stock had a trading volume of 868,200 shares, compared to its average volume of 737,213. Encompass Health has a fifty-two week low of $38.24 and a fifty-two week high of $52.58. The stock has a market capitalization of $5,158.37, a P/E ratio of 18.37, a price-to-earnings-growth ratio of 1.81 and a beta of 0.54. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 1.89.
ILLEGAL ACTIVITY WARNING: “Craig Hallum Reaffirms Buy Rating for Encompass Health (EHC)” was originally posted by Stock Observer and is the property of of Stock Observer. If you are reading this report on another site, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.thestockobserver.com/2018/01/12/craig-hallum-reaffirms-buy-rating-for-encompass-health-ehc.html.
About Encompass Health
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.